Publication: Targeting miR-155 suppresses proliferation and induces apoptosis of HL-60 cells by targeting Slug/PUMA signal
Authors
Liang, Hui ; Dong, Ziyan ; Liu, Jiang Feng ; Chuang, Wei ; Gao, Li Zhen ; Ren, Yu Guo
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia. Departamento de BiologĂa Celular e HistologĂa
publication.page.editor
publication.page.department
DOI
DOI: 10.14670/HH-11-837
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Recent studies have shown that high miR155 expression was associated with poor prognosis in
patients with acute myelogeneous leukemia (AML).
Furthermore, targeting miR-155 results in monocytic
differentiation and apoptosis. However, the exact role
and mechanisms of miR-155 in human AML remains
speculative. HL-60 cells were treated with anti-miR-155
for 72 h. Cell growth and apoptosis in vitro were
detected by MTT, BrdU proliferation, colony formation
and flow cytometry assay. The effect of anti-miR-155 on
growth of HL-60 cells was also evaluated in a leukemia
mouse model. Slug cDNA and PUMA siRNA
trannsfection was used to assess the signal pathway.
Different protein expression was detected by western
blot assay and quantitative reverse transcriptase
polymerase chain reaction (qRT-PCR) assay. The results
shown that targeting miR-155 resulted in a 24-fold
decrease of miR-155 expression compared to negative
control in the HL-60 cells. Targeting miR-155
significantly downregulated Slug and upregulated
PUMA expression, and decreased HL-60 cell growth by
70% , impaired colony formation by approximately
60%, and increased HL-60 cell apoptosis by 45%.
Targeting PUMA reversed miR-155 sliencing-induced
proliferation and apoptosis of HL-60 cells. Restoration
of Slug decreased PUMA expression. In murine
engraftment models of HL-60 cells, we showed that
targeting miR-155 was able to reduce tumor growth.
This was accompanied with decreased Slug expression
and increased PUMA expression in these tumors.
Collectively, our findings strongly suggest targeting
miR-155 exhibited in vivo and in vitro antileukemic
activities in AML through a novel mechanism resulting
in inhibition of Slug expression and increase of PUMA
expression.
publication.page.subject
Citation
Histology and Histopathology, Vol.32, nÂş9, (2017)
item.page.embargo
Ir a EstadĂsticas
Este Ătem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-nc-nd/4.0/